[Edematous syndrome and alithiasic cholecystitis induced by gabapentin].
Guéguen
A
A
Guy
C
C
Cartry
O
O
Bouchou
K
K
Gouilloud
S
S
Cathébras
P
P
D000085:Acetates / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002764:Cholecystitis / Q000209:etiology*; D003509:Cyclohexanecarboxylic Acids; D004487:Edema / Q000209:etiology*; D004827:Epilepsy / Q000188:drug therapy; D000077206:Gabapentin; D006801:Humans; D008297:Male; D013577:Syndrome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin